Skip to content

Author

C. Shard

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells.

Histone lysine demethylase 4 (KDM4) enzymes are frequently overexpressed in cancer and are considered to be promising therapeutic targets. QC6352, which is widely used as a best-in-class KDM4 chemical probe, shows potent antitumor activity across cancer models. Using comprehensive chemical biology approaches in gliobla...

Jayden Sterling, Jacinda R. Holtsmark, George L. Joun et al. · 1 citation
Open access Sep 2026

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma

It is found that FAP+ pericytes are linked to increased monocyte recruitment and differentiation into tumor-associated macrophages, particularly those with an M2-like, tumor-supportive phenotype, and Targeting this stromal population may offer new therapeutic avenues to reprogram tumor-associated immune responses in GB...

Magdalena Houdova Megova, C. Shard, B. Výmolová et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.